KMDA Earnings

KMDA reported its earnings on 2026-03-11, showcasing a revenue of 44.68M against an estimate of 45.73M, resulting in a -2.3% surprise. The EPS was 0.06, surpassing the expected 0.09 by -33.33%. The stock experienced a -4.58% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following KMDA's earnings announcement on 2026-03-11, the stock price moved by -4.58% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, KMDA's stock price tends to shift by an average of -0.74% in the 10 days leading up to earnings and -1.3% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate KMDA's annual revenue to reach 45.67M, while the EPS is projected at 0.08. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between KMDA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, KMDA's stock price typically moves by -0.74% in the 10 days before its earnings and -1.3% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.08 and revenue of 45.67M.

The earnings call reveals strong financial performance with a 12% revenue increase and 23% EBITDA growth. The company maintains its guidance, indicating confidence in future growth. The dividend declaration and plans for biosimilar launches further support a positive outlook. While gross margins slightly declined, the overall financial health remains robust. The Q&A section addresses concerns effectively, reinforcing management's confidence. Given the positive financial metrics, strategic plans, and shareholder returns, the stock price is likely to see a positive movement in the short term.